🔴 Veraxa Biotech is trading 6.2% down in after-hours trading after reversing a 15.60% regular-session gain

Veraxa Biotech is trading 6.21% lower at $1.18 after reversing its 15.60% regular-session gain, with no clear after-hours catalyst identified.

• It closed at $1.26 on October 9, 2026.
• No company-specific announcement for October 9 was identified. Its FDA-aligned testing strategy was announced October 7, but available evidence does not establish it as the cause of the decline.
• The broad market finished higher.